Scientific Sessions 2024  /  Antiarrhythmic Drugs in Atrial Fibrillation: Putting the Guideline Into Practice  /  Antiarrhythmic Drugs in Atrial Fibrillation: Putting the Guideline Into Practice
Logo

American Heart Association

  144
  0

Final ID:

Antiarrhythmic Drugs in Atrial Fibrillation: Putting the Guideline Into Practice

  • Curtis, Anne  ( University at Buffalo , Buffalo , New York , United States )
  • Singh, Jagmeet  ( Mass General Hospital , Boston , Massachusetts , United States )
  • Zeitler, Emily  ( Dartmouth-Hitchcock Medical Center , Lebanon , New Hampshire , United States )
    • Author Disclosures:
    Anne Curtis: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Speaker:Sanofi Aventis:Active (exists now) ; Consultant:Janssen Pharmaceuticals:Active (exists now) ; Consultant:Abbott:Active (exists now) ; Speaker:Medtronic:Active (exists now) | Jagmeet Singh: DO NOT have relevant financial relationships | Emily Zeitler: DO have relevant financial relationships ; Advisor:Medtronic:Active (exists now) ; Advisor:V-wave:Active (exists now) ; Researcher:Biosense Webster:Active (exists now) ; Researcher:Sanofi:Active (exists now) ; Consultant:Biosense Webster:Active (exists now) ; Advisor:Boston Scientific:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Antiarrhythmic Drugs in Atrial Fibrillation: Putting the Guideline Into Practice

Sunday, 11/17/2024 , 11:15AM - 12:00PM

Learning Studio

More abstracts from these authors:
Can We Achieve Optimal AV Synchrony in Leadless VDD Pacing?

El-chami Mikhael, Zeitler Emily, Tompkins Christine

Leadless pacing can be synchronous pacing - new technologies

Singh Jagmeet

You have to be authorized to contact abstract author. Please, Login
Not Available